Total Payments
$19,618
2024 Payments
$2,076
Companies
53
Transactions
608
Medicare Patients
6,918
Medicare Billing
$780,394
Payment Breakdown by Category
Food & Beverage$19,592 (99.9%)
Education$25.93 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,592 | 605 | 99.9% |
| Education | $25.93 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,424 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,327 | 57 | $0 (2024) |
| Amgen Inc. | $2,026 | 43 | $0 (2024) |
| Novo Nordisk Inc | $1,818 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,390 | 56 | $0 (2024) |
| ABBVIE INC. | $847.36 | 58 | $0 (2024) |
| PFIZER INC. | $843.13 | 55 | $0 (2024) |
| Lilly USA, LLC | $812.31 | 39 | $0 (2024) |
| Astellas Pharma US Inc | $796.24 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $615.33 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,076 | 46 | AstraZeneca Pharmaceuticals LP ($824.50) |
| 2023 | $2,384 | 88 | Otsuka America Pharmaceutical, Inc. ($383.47) |
| 2022 | $2,976 | 92 | Lilly USA, LLC ($479.92) |
| 2021 | $2,436 | 88 | Amgen Inc. ($396.13) |
| 2020 | $679.74 | 23 | Amarin Pharma Inc. ($165.36) |
| 2019 | $3,773 | 102 | AstraZeneca Pharmaceuticals LP ($604.46) |
| 2018 | $2,658 | 77 | Janssen Pharmaceuticals, Inc ($657.73) |
| 2017 | $2,636 | 92 | Janssen Pharmaceuticals, Inc ($621.17) |
All Payment Transactions
608 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: VTE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $106.83 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $116.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Obesity | ||||||
| 08/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $123.01 | General |
| Category: Respiratory | ||||||
| 08/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Biological | ||||||
| 07/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Cardiology | ||||||
| 07/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $124.27 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.27 | General |
| Category: Obesity | ||||||
| 06/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: UROLOGY | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $122.60 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,606 | 2,379 | $662,350 | $191,731 |
| 2022 | 23 | 1,845 | 2,715 | $708,943 | $208,500 |
| 2021 | 21 | 1,719 | 2,505 | $643,658 | $208,427 |
| 2020 | 25 | 1,748 | 2,589 | $635,855 | $171,735 |
Total Patients
6,918
Total Services
10,188
Medicare Billing
$780,394
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 532 | 911 | $276,944 | $74,038 | 26.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 361 | 361 | $129,238 | $45,569 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 228 | 260 | $53,560 | $14,841 | 27.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 83 | 93 | $37,665 | $11,315 | 30.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 32 | 33 | $21,615 | $6,946 | 32.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 20 | 180 | $26,460 | $6,428 | 24.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 21 | 164 | $31,652 | $5,926 | 18.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 33 | 39 | $18,096 | $5,896 | 32.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 27 | 27 | $12,474 | $4,364 | 35.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 25 | 25 | $11,950 | $4,033 | 33.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 56 | $9,128 | $4,028 | 44.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $11,016 | $1,897 | 17.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 57 | 57 | $4,161 | $1,719 | 41.3% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 12 | 20 | $6,020 | $1,620 | 26.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 34 | $4,080 | $1,045 | 25.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 42 | $3,780 | $1,009 | 26.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 21 | $3,171 | $856.17 | 27.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 20 | $1,340 | $202.86 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 579 | 1,030 | $313,120 | $86,807 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 302 | 302 | $107,561 | $39,288 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 401 | 481 | $99,086 | $29,085 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 67 | $27,135 | $9,144 | 33.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 39 | 181 | $26,607 | $7,096 | 26.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 36 | 157 | $30,301 | $6,829 | 22.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 24 | 26 | $17,030 | $5,750 | 33.8% |
About Dr. Thomas Samaras, M.D
Dr. Thomas Samaras, M.D is a Family Medicine healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821007550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Samaras, M.D has received a total of $19,618 in payments from pharmaceutical and medical device companies, with $2,076 received in 2024. These payments were reported across 608 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($19,592).
As a Medicare-enrolled provider, Samaras has provided services to 6,918 Medicare beneficiaries, totaling 10,188 services with total Medicare billing of $780,394. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Virginia Beach, VA
- Active Since 08/05/2006
- Last Updated 12/01/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821007550
Products in Payments
- FARXIGA (Drug) $1,907
- XARELTO (Drug) $1,838
- JARDIANCE (Drug) $987.87
- Repatha (Biological) $796.41
- Ozempic (Drug) $653.51
- Aimovig (Biological) $554.20
- Otezla (Drug) $517.72
- NURTEC ODT (Drug) $492.69
- REXULTI (Drug) $461.81
- INVOKANA (Drug) $458.34
- UBRELVY (Drug) $431.83
- Wegovy (Drug) $417.85
- TRELEGY ELLIPTA (Drug) $406.01
- BREZTRI (Drug) $383.57
- Vascepa (Drug) $374.26
- SYMBICORT (Drug) $358.88
- Saxenda (Drug) $355.16
- ELIQUIS (Drug) $351.57
- AIRSUPRA (Drug) $344.35
- VRAYLAR (Drug) $309.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Virginia Beach
Dr. Michael Charles, M.d, M.D
Family Medicine — Payments: $24,592
Family Medicine $24,592
Dr. Jim-David Gaglione, Md, MD
Family Medicine — Payments: $24,428
Family Medicine $24,428
Glenn Mcdermott, Md, MD
Family Medicine — Payments: $20,537
Family Medicine $20,537
Nasser Hambaz, Md, MD
Family Medicine — Payments: $18,767
Family Medicine $18,767
Dr. Nathan Riles, M.d, M.D
Family Medicine — Payments: $14,874
Family Medicine $14,874
Randall Fedro, Md, MD
Family Medicine — Payments: $14,241
Family Medicine $14,241